---
title: "Aarti Pharmalabs Ltd (AARTIPHARM) — Share Price, Financials & Analysis"
symbol: "AARTIPHARM"
company: "Aarti Pharmalabs Ltd"
canonical: "https://tapetide.com/stocks/AARTIPHARM"
isin: "INE0LRU01027"
nse_symbol: "AARTIPHARM"
bse_code: "543748"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 7434.39
generated_at: "2026-09-13T18:32:29.743Z"
---

# Aarti Pharmalabs Ltd (AARTIPHARM)

Canonical page: https://tapetide.com/stocks/AARTIPHARM

## Company

- **NSE Symbol:** AARTIPHARM
- **BSE Code:** 543748
- **ISIN:** INE0LRU01027
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2023-01-30
- **CEO:** Ms. Hetal Gogri Gala
- **Employees:** 2162
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** aartipharmalabs.com

## About

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals[1]

## Latest Price

- **Price:** ₹826.95
- **Change:** +1.2 (+0.15%)
- **Open:** ₹814
- **Day High:** ₹833
- **Day Low:** ₹814
- **Previous Close:** ₹825.75
- **Volume:** 268696
- **As Of:** 2026-09-11T10:24:10+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:28.891726Z.

- **Market Cap:** ₹7434.39 Cr
- **Classification:** Microcap
- **P/E (reported):** 35.1
- **P/E (TTM):** 35.17
- **EPS (TTM):** ₹23.51
- **EPS (reported):** ₹24.86
- **Book Value:** ₹234.3
- **Price to Book:** 3.52
- **Dividend Yield:** 0.42%
- **ROE:** 13.69%
- **ROCE:** 17.23%
- **Debt to Equity:** 0.35
- **Revenue (yearly):** ₹1819.44 Cr
- **Net Income:** ₹190.75 Cr
- **EBITDA:** ₹366.41 Cr
- **52-Week High:** ₹946.1
- **52-Week Low:** ₹585
- **RSI (14):** 51.24

## Tapetide Score

- **Score:** 36 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Flat
- **Percentile:** 7.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 26.46 | 9% |
| growth | 17.25 | 9% |
| momentum | 58.2 | 12% |
| ownership | 25.5 | 24% |
| quality | 40.62 | 22% |
| valuation | 52.58 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 3.53 times its book value
- Company has a low return on equity of 11.9% over last 3 years.
- Promoter holding has decreased over last 3 years: -3.12%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 53.25% | 32.56% | 331.56% |
| ebitda margin growth | 13.65% | -10.7% | -5.27% | 14.47% |
| net income growth | 24.55% | -29.97% | -3% | 55.97% |
| revenue growth | -8.81% | -14.39% | -2% | 8.64% |
| roce | 15.63% | 2.38% | 0.47% | 12.13% |
| roe | 24.57% | 10.94% | 12.82% | -777.72% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 440 | 449 | 506 | 555 | 458 | 538 | 564 | 386 | 418 | 432 | 583 | 536 |
| Expenses | 352 | 353 | 388 | 459 | 364 | 409 | 418 | 293 | 344 | 330 | 470 | 400 |
| Operating Profit | 88 | 96 | 118 | 96 | 94 | 129 | 146 | 93 | 74 | 102 | 113 | 136 |
| OPM % | 20 | 21 | 23 | 17 | 20 | 24 | 26 | 24 | 18 | 24 | 19 | 25 |
| Other Income | 1 | 1 | 2 | 2 | 4 | 5 | -2 | 2 | 0 | 2 | 14 | 8 |
| Interest | 4 | 4 | 5 | 5 | 6 | 10 | 7 | 7 | 11 | 13 | 17 | 13 |
| Depreciation | 18 | 19 | 19 | 20 | 21 | 23 | 23 | 23 | 25 | 29 | 28 | 30 |
| Profit before tax | 67 | 74 | 96 | 74 | 72 | 101 | 115 | 65 | 39 | 63 | 82 | 101 |
| Tax % | 23 | 29 | 32 | 25 | 24 | 26 | 23 | 24 | 28 | 24 | 25 | 25 |
| Net Profit | 52 | 53 | 65 | 55 | 55 | 74 | 88 | 50 | 28 | 48 | 61 | 76 |
| EPS in Rs | 5.72 | 5.82 | 7.2 | 6.12 | 6.03 | 8.16 | 9.75 | 5.46 | 3.08 | 5.29 | 6.74 | 8.4 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 1200 | 1945 | 1853 | 2115 | 1819 | 1969 |
| Expenses | 0 | 993 | 1603 | 1467 | 1651 | 1450 | 1543 |
| Operating Profit | 0 | 207 | 342 | 386 | 464 | 369 | 426 |
| OPM % | — | 17 | 18 | 21 | 22 | 20 | 22 |
| Other Income | 0 | 3 | 2 | 5 | 10 | 15 | 23 |
| Interest | 0 | 12 | 21 | 17 | 27 | 47 | 53 |
| Depreciation | 0 | 42 | 63 | 73 | 87 | 104 | 112 |
| Profit before tax | 0 | 155 | 261 | 300 | 361 | 233 | 284 |
| Tax % | — | 21 | 26 | 28 | 24 | 25 | — |
| Net Profit | 0 | 122 | 193 | 217 | 272 | 175 | 213 |
| EPS in Rs | — | — | 21.35 | 23.93 | 30.05 | 19.27 | 23.51 |
| Dividend Payout % | — | 0 | 9 | 13 | 17 | 18 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.25 | 0.25 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 1386 | 1513 | 1712 | 1945 | 2079 |
| Borrowings | 0 | 338 | 215 | 285 | 413 | 754 |
| Other Liabilities | 0 | 315 | 470 | 540 | 503 | 603 |
| Total Liabilities | 0 | 2040 | 2244 | 2582 | 2906 | 3482 |
| Fixed Assets | 0 | 782 | 926 | 1033 | 1137 | 1525 |
| CWIP | 0 | 187 | 102 | 137 | 374 | 305 |
| Investments | 0 | 32 | 87 | 107 | 77 | 194 |
| Other Assets | 0 | 1038 | 1130 | 1305 | 1319 | 1457 |
| Total Assets | 0 | 2040 | 2244 | 2582 | 2906 | 3482 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | -44 | 250 | 216 | 332 | 262 |
| Cash from Investing Activity | 0 | -139 | -158 | -215 | -414 | -431 |
| Cash from Financing Activity | 0 | 260 | -163 | 10 | 65 | 171 |
| Net Cash Flow | 0 | 78 | -71 | 12 | -17 | 2 |
| Free Cash Flow | 0 | -185 | 130 | 18 | -112 | -186 |
| CFO/OP | — | -11 | 91 | 71 | 85 | 84 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 115 | 84 | 102 | 99 | 117 |
| Inventory Days | — | 272 | 188 | 230 | 190 | 280 |
| Days Payable | — | 123 | 106 | 135 | 90 | 146 |
| Cash Conversion Cycle | — | 264 | 166 | 197 | 200 | 251 |
| Working Capital Days | — | 111 | 94 | 110 | 105 | 90 |
| ROCE % | — | 19 | 16 | 17 | 17 | 11 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 46.3% | 46.46% | 46.46% | 46.46% | 46.1% | 44.66% | 44.29% | 43.72% | 42.88% | 43.1% | 43.08% | 42.86% |
| FIIs | 8.45% | 8.16% | 8.32% | 7.06% | 7.38% | 8.64% | 7.36% | 7.35% | 8.02% | 7.68% | 8.39% | 8.17% |
| DIIs | 10.51% | 9.91% | 9.97% | 11.47% | 11.35% | 10.36% | 7.53% | 7.8% | 6.96% | 7.66% | 7.41% | 7.22% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 29.13% | 29.74% | 29.71% | 29.57% | 29.45% | 30.39% | 34.1% | 34.43% | 35.39% | 34.85% | 34.29% | 34.39% |
| Others | 5.59% | 5.72% | 5.52% | 5.43% | 5.71% | 5.94% | 6.71% | 6.69% | 6.74% | 6.7% | 6.82% | 7.35% |
| No. of Shareholders | 226286 | 215796 | 204122 | 189012 | 185436 | 185111 | 196314 | 187039 | 190655 | 184489 | 179373 | 176506 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 4 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 851.68 | Sell |
| EMA (10) | 842.45 | Sell |
| SMA (20) | 845.12 | Sell |
| EMA (20) | 832.94 | Sell |
| SMA (50) | 770.3 | Buy |
| EMA (50) | 788.26 | Buy |
| SMA (100) | 730.21 | Buy |
| EMA (100) | 754.61 | Buy |
| SMA (200) | 723.05 | Buy |
| EMA (200) | 745.98 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 51.55 | Neutral |
| MACD (12,26,9) | 18.8 | Sell |
| Stochastic (14,3,3) | 21.99 | Neutral |
| ADX (14) | 31.19 | Buy |
| Williams %R (14) | -80.08 | Buy |
| ATR (14) | 33.5 | High Volatility |
| ROC (12) | -1.16 | Sell |
| Stoch RSI (14) | 2.34 | Buy |
| UO (7,14,28) | 33.44 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 0 | 0% |
| Hold | 1 | 100% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:47:27.719107+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2eeac16-c517-4725-acb9-317d28392631.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e1f5073-a656-4c89-9536-79dd39e641bf.pdf) |
| 2026-08-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dc57408-628b-41bb-8999-c6cd7630dd59.pdf) |
| 2026-08-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b43ff531-c497-44f0-bbf2-1364c0c1f563.pdf) |
| 2026-08-29 | [Notice Of 7Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28a72f62-10f9-4537-aff4-5b1302a9b48c.pdf) |
| 2026-08-29 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d6e3cf3-9645-4dc5-acda-8dc1237bb666.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37a79ae9-7a08-4805-ae2d-2ef2c60012bd.pdf) |
| 2026-08-17 | [Record Date For Dividend For FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6506463-21a4-43dc-ab84-29f28a25fa73.pdf) |
| 2026-08-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a934e56-bc63-49b8-aaba-8a156aebf7a8.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 07 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=490e0c68-1c90-4577-9c57-e84b3c3ac936.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ed3c9b8-f4a2-4676-97d3-b3c701e80089.pdf) |
| 2026-06-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ceeed49-b65b-4deb-8148-6c35994c140b.pdf) |
| 2026-02-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8abb8d32-20d7-4c66-b3f7-a4a4481d72f2.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=085f5cd1-1ce8-443f-8f57-58a02d1d7258.pdf) |
| 2025-08-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=913c9018-5c3a-45aa-807f-ee7a59e50b76.pdf) |
| 2025-05-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7381a766-ad0c-4780-a1cc-833b7bee3c29.pdf) |
| 2025-02-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=691228af-f2ae-415b-9a46-f5b6137b6a03.pdf) |
| 2024-11-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2da4905-4ad1-46bd-8d29-2b74ca8afda4.pdf) |
| 2024-08-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae85bac-cde9-46c5-8997-87a988f6e0af.pdf) |
| 2024-05-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53d2104f-90fd-42a1-947c-3f924a2a6618.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10d019c8-952d-4257-b0a1-33f5617e721c.pdf) |
| 2026-05-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1bc07c9-2385-4f56-a43c-cb4be188d309.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c371bec7-ba30-43fc-831f-cf12647c167a.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46d58674-e6a3-408b-8347-9ef5132efe9b.pdf) |
| 2025-09-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfbef63c-c610-46a5-97e5-f2e40eb3bff2.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4a5587f-7ee8-4fb7-8ee5-07d93610c2a8.pdf) |
| 2025-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df45d866-44c7-4002-af15-877424037137.pdf) |
| 2025-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ded98d2-7458-423b-ba41-f7de69b66199.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed8a6d03-5e28-4ac8-87d2-29bddedd0ad6.pdf) |
| 2024-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a24dcd5f-351c-4b14-9722-b5d8b340a486.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20fa6ca3-c329-43b6-bbf7-0d3b44ddb71d.pdf) |
| 2026-05-26 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e56c9d00-e203-4500-bc6f-de8390ec41a6.pdf) |
| 2023-11-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72036700-355e-42f7-bac5-5b0f29b93386.pdf) |
| 2023-08-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cfa6d16-1c74-4758-9151-23483a941121.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8c8caae-d3a9-42a3-bbd5-9da314b0d208.pdf) |
| 2026-05-26 | [Audited Financial Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86d3a165-e5de-49dc-ba89-6a911e7b9001.pdf) |
| 2026-02-09 | [Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=672dd8eb-5635-41b0-b0b8-2e277ec67374.pdf) |
| 2025-11-09 | [Financial Results For Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=121daa9d-5c82-4fe8-b1ff-6e96e46485c8.pdf) |
| 2025-08-12 | [Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0062c62b-b124-472a-8148-baa7a1f61e66.pdf) |
| 2025-05-10 | [Results For The Financial Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a152e817-846d-4623-ab63-d7cbabafeb05.pdf) |
| 2025-02-05 | [Financial Results For Quarter Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7575e0ec-593a-4389-b0a9-19feb368edea.pdf) |
| 2024-08-05 | [Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69c96790-269c-414a-ab77-806aeb74fe28.pdf) |
| 2024-05-13 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0346392-c27d-4b04-bd71-73e3d122cfe3.pdf) |
| 2024-05-13 | [Results- Financials For The Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be682ba-c3f2-464f-8eb1-198eb09a09f7.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bfbef63c-c610-46a5-97e5-f2e40eb3bff2.pdf) |
| Sep 2023 | [Concall - Sep 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/952fd5aa-2c88-42e5-b07f-bd0624195579.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/085f5cd1-1ce8-443f-8f57-58a02d1d7258.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2da4905-4ad1-46bd-8d29-2b74ca8afda4.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c72a03d1-5884-456a-ab15-09a439124b33.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b1bc07c9-2385-4f56-a43c-cb4be188d309.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b1bc07c9-2385-4f56-a43c-cb4be188d309.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7381a766-ad0c-4780-a1cc-833b7bee3c29.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53d2104f-90fd-42a1-947c-3f924a2a6618.pdf) |
| Jun 2026 | [Concall - Jun 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ceeed49-b65b-4deb-8148-6c35994c140b.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Apr - Regulation 74(5) compliance certificate for quarter ended March 31, 2026; no shareholder requests received. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Regulation 74(5) compliance certificate for quarter ended March 31, 2026; no shareholder requests received.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d9871a3-3ba0-47c1-bc24-00602110bc4f.pdf) |
| 7 Apr - Newspaper Advertisement for the Second 100-Day Campaign - "Saksham Niveshak" | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Apr - Newspaper Advertisement for the Second 100-Day Campaign - "Saksham Niveshak"](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c5bc2124-9a33-4042-a6b8-f7b6514b744b.pdf) |
| 4 Feb - Publication of advance notice of Board Meeting scheduled to be held on 13th February, 2026 to consider and approve the Unaudited Financial Results (Standalone & … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Feb - Publication of advance notice of Board Meeting scheduled to be held on 13th February, 2026 to consider and approve the Unaudited Financial Results (Standalone & …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f2255fdc-0ce3-4183-92b1-94b0ad21fbae.pdf) |
| 4 Feb - CEO Alok Gupta resigned effective close of business 31 January 2026. | [Announcement under Regulation 30 (LODR)-Cessation 4 Feb - CEO Alok Gupta resigned effective close of business 31 January 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f69780a8-c8d9-43d7-b8bf-9e3827400473.pdf) |
| 4 Apr - Renil Rajendra Gogri created pledge on 15,19,919 Aarti Pharmalabs shares on 25-Mar-26. | [Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 4 Apr - Renil Rajendra Gogri created pledge on 15,19,919 Aarti Pharmalabs shares on 25-Mar-26.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48BE0B67_E16C_4F13_B0C3_368533E89E3D_102250.pdf) |
| 4 Apr - Aarti Pharmalabs launches IEPFA Saksham Niveshak campaign from April 1 to July 9, 2026. | [Intimation Regarding Second 100-Day Campaign - 'Saksham Niveshak' 4 Apr - Aarti Pharmalabs launches IEPFA Saksham Niveshak campaign from April 1 to July 9, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e312edf0-7a9b-4d20-a3ac-a35dff0b986f.pdf) |
| 27 Mar - US FDA inspected Unit-IV Tarapur; Form 483 with one procedural observation issued, corrective actions to be submitted. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Mar - US FDA inspected Unit-IV Tarapur; Form 483 with one procedural observation issued, corrective actions to be submitted.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fcf33b59-5c9d-4550-ac41-9742efde7da4.pdf) |
| 27 Mar - US FDA inspected Unit-IV Tarapur; Form 483 issued with one procedural observation on 27-Mar-2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 27 Mar - US FDA inspected Unit-IV Tarapur; Form 483 issued with one procedural observation on 27-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/238bda51-74b7-4df4-bc29-4c1ca7b24f5d.pdf) |
| 24 Mar - Dimethyl sulphate leak at Tarapur Unit‑VI on 22 Mar 2026; 22 workers hospitalised, FIR filed; operations restored within 24 hours. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 24 Mar - Dimethyl sulphate leak at Tarapur Unit‑VI on 22 Mar 2026; 22 workers hospitalised, FIR filed; operations restored within 24 hours.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/33f2e79d-d8eb-4c5f-9caa-2e8e253139cd.pdf) |
| 17h - Promoter Renil Rajendra Gogri created pledge on 15,19,919 shares on 25-Mar-26. | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 17h - Promoter Renil Rajendra Gogri created pledge on 15,19,919 shares on 25-Mar-26.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/CD57356D_E00D_4E62_928F_E3A48A9115BA_101656.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69fd87cd-446d-4633-aa91-782acecc209b.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c5e082b-883a-47e6-a869-f71cc575cccc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d37b095a-57a7-4d0d-af8c-d5f2bd082a66.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06ad8167-9e53-4484-bbb2-454e9ed30197.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20aa67cf-f69b-4811-ab99-f7cec4fbd94a.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cd20a5ab-8db1-4388-8c81-85c0fe9e6480.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532029/76271532029.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532029/71681532029.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532029/67836532029.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532029/5320290319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:32:29.743Z.